If the original gene produces a protein that actively causes an issue in the body, versus if the gene produces a broken protein that simply fails to do its job.
In the first case, a partial replacement means that the original active protein continues to cause the disease.
In the second case, a partial replacement means that the repaired protein begins expressing itself.
In either case, there may or may not be a linear correlation between the percentage of fixed proteins and the severity of the disease, and that relationship probably isn't well understood in most disease cases, but a partial replacement is likely much more beneficial in the second case, rather than the first.
That is why these initial test are done on chemo patients, so that we can isolate testing of the method of treatment without needed to know what amount of the original tissue needs to be replaced.
There is still a long complicated road ahead. Not a lot of organs get fully replaced in other procedures.
1. You only give the patient a small number of edited cells. You want those cells to multiply and replace the existing cells. If you don't remove the existing cells, the edited cells aren't going to reproduce very fast because the body has a feedback loop and is saying "we have enough bone marrow cells now, so no need to make more".
2. Host versus graft disease. The old immune system will attack the new immune system cells.
But you’d also gain the donor’s immunity, and if they’ve been vaccinated, the recipient would have that immunity as well.
I've heard it discussed as a possible way to treat autoimmune diseases like MS.
Interesting that they need to kill the remaining bone marrow cells. I wonder what happens when they skip that step. Do the modified cells still reproduce, resulting in a partially effective treatment? Are they targeted by the immune system and eliminated? Are they just out-reproduced by the normal cells and fade into irrelevance?